Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
12/2003
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof
12/30/2003US6670363 Azole compounds as therapeutic agents for fungal infections
12/25/2003US20030236419 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides
12/25/2003US20030236413 Catalysis in presence of a metallic element, an imine ligand and nitrogen compound as chelating compound, forming a chemical intermediates in the agrochemical and pharmaceutical fields
12/25/2003US20030236256 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/25/2003US20030236231 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003068725A3 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
12/24/2003WO2003039454A3 Beta-secretase inhibitors and methods of use
12/24/2003WO2002092608A3 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
12/24/2003CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003WO2001078648A3 6-methylnicotinamide derivatives as antiviral agents
12/18/2003US20030232860 Medicine comprising dicyanopyridine derivative
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003CN1462270A Imidazole derivatives or their salts
12/17/2003CN1131217C Phenylazole compound, process for producing the same and drugs for hyperlipemia
12/17/2003CN1131216C Condensed 1,2-indene dihydride and its salt for medicine its preparation method and application
12/16/2003US6664398 Derivatives of erythromycin, their preparation process and their use as medicaments
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003CA2195125C Difluorostatone antiviral agents
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101966A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003US20030229099 Novel farnesyl protein transferase inhibitors as antitumor agents
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229082 Viricides
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229066 Central nervous system diosrders; psychological disorders
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660753 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225147 Inhibit activity of protein kinases; for tumor growth, angiogenesis, viral infection, autoimmune disease or neurodegenerative disorder
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003CN1129585C Aminosulfonylureas with herbicidal acivity
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
11/2003
11/27/2003WO2003097612A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/27/2003WO2003048078A3 Production of ionic liquids
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220495 Inhibitors of farnesyl protein transferase
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220326 Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
11/27/2003CA2482151A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/26/2003EP1363903A1 Indole derivatives and their use as gnrh antagonists
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
11/26/2003EP1363884A2 Pyridine-substituted benzanilides as potassium ion channel openers
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003US6653330 Amide-type triazole compounds
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2003094839A2 Pyrimidinone compounds, compositions and methods
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216373 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/20/2003CA2485148A1 Pyrimidinone compounds, compositions and methods
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361851A1 Primary intermediates for oxidative coloration of hair
11/19/2003EP1095024B1 Method for producing carbonyl diimidazoles
11/19/2003EP0870765B1 Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds
11/18/2003US6649717 Stabilized composition of O- and N-vinyl compounds and use of ammonium salts as stabilizers
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649568 Brassinosteroid biosynthesis inhibitor
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 163